recombinant SARS-CoV-2 S-Trimer vaccine
/ Wuhan Binhui Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 29, 2025
Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years
(clinicaltrials.gov)
- P1 | N=80 | Terminated | Sponsor: Binhui Biopharmaceutical Co., Ltd. | Recruiting ➔ Terminated; Company strategy adjustment
Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1